Compare SFHG & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFHG | EVGN |
|---|---|---|
| Founded | 1993 | 1999 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | Publishing | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 11.1M |
| IPO Year | 2022 | 2013 |
| Metric | SFHG | EVGN |
|---|---|---|
| Price | $2.13 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.3K | ★ 311.4K |
| Earning Date | 10-29-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $81.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $0.35 |
| 52 Week High | $3.17 | $1.49 |
| Indicator | SFHG | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.91 | 35.85 |
| Support Level | $1.95 | $0.36 |
| Resistance Level | $2.56 | $0.84 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 21.88 | 18.13 |
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.